Your browser doesn't support javascript.
loading
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Pemmaraju, Naveen; Kantarjian, Hagop; Sweet, Kendra; Wang, Eunice; Senapati, Jayastu; Wilson, Nathaniel R; Konopleva, Marina; Frankel, Arthur E; Gupta, Vikas; Mesa, Ruben; Ulrickson, Matthew; Gorak, Edward; Bhatia, Sumeet; Budak-Alpdogan, Tulin; Mason, James; Garcia-Romero, Maria Teresa; Lopez-Santiago, Norma; Cesarman-Maus, Gabriela; Vachhani, Pankit; Lee, Sangmin; Bhatt, Vijaya Raj; Blum, William; Walter, Roland B; Bixby, Dale; Gojo, Ivana; Duvic, Madeleine; Rampal, Raajit K; de Lima, Marcos; Foran, James; Fathi, Amir T; Hall, Aric Cameron; Jacoby, Meagan A; Lancet, Jeffrey; Mannis, Gabriel; Stein, Anthony S; Mims, Alice; Rizzieri, David; Olin, Rebecca; Perl, Alexander; Schiller, Gary; Shami, Paul; Stone, Richard M; Strickland, Stephen; Wieduwilt, Matthew J; Daver, Naval; Ravandi, Farhad; Vasu, Sumithira; Guzman, Monica; Roboz, Gail J; Khoury, Joseph.
Afiliação
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sweet K; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Wang E; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wilson NR; Department of Internal Medicine, The University of Texas School of Health Sciences at Houston, Houston, TX.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Frankel AE; West Palm Beach VA Medical Center, West Palm Beach, FL.
  • Gupta V; MPN Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Mesa R; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX.
  • Ulrickson M; Banner MD Anderson Cancer Center, Gilbert, AZ.
  • Gorak E; Baptist MD Anderson Cancer Center, Jacksonville, FL.
  • Bhatia S; Community Health Network, Indianapolis, IN.
  • Budak-Alpdogan T; Department of Hematology, MD Anderson Cancer Center at Cooper, Cooper Health University, Camden, NJ.
  • Mason J; Scripps MD Anderson Cancer Center, La Jolla, CA.
  • Garcia-Romero MT; Department of Dermatology, National Pediatrics Institute, Mexico City, Mexico.
  • Lopez-Santiago N; Division of Hematology/Oncology, Hematology Service, National Pediatrics Institute, Mexico City, Mexico.
  • Cesarman-Maus G; Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Vachhani P; O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL.
  • Lee S; Division of Hematology and Oncology, Department of Medicine, Clinical and Translational Leukemia Program, Weill Cornell Medicine, New York, NY.
  • Bhatt VR; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE.
  • Blum W; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA.
  • Walter RB; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Bixby D; Department of Hematology/Oncology, University of Michigan, Ann Arbor, MI.
  • Gojo I; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Duvic M; Division of Internal Medicine, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Rampal RK; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.
  • de Lima M; Ohio State University, Columbus, OH.
  • Foran J; Department of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL.
  • Fathi AT; Harvard Medical School, Leukemia Program, Medicine, Massachusetts General Hospital, Boston, MA.
  • Hall AC; Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin School of Medicine and Public Health, Madison, WI.
  • Jacoby MA; Department of Medicine, Washington University Medical School, St. Louis, MO.
  • Lancet J; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Mannis G; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.
  • Stein AS; Department of Hematology/Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA.
  • Mims A; Wexner Medical Center, James Cancer Hospital, The Ohio State University, Columbus, OH.
  • Rizzieri D; Novant Health Cancer Institute, Winston Salem, NC.
  • Olin R; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.
  • Perl A; Division of Hematology-Oncology, Perelman School of Medicine at the University of Pennsylvania, Abramson Cancer Center, Leukemia Program, Philadelphia, PA.
  • Schiller G; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Shami P; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Stone RM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Strickland S; Vanderbilt-Ingram Cancer Center, Nashville, TN.
  • Wieduwilt MJ; Division of Bone Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, CA.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Vasu S; Division of Hematology, Bone Marrow Transplantation and Cellular Therapies Program, The Ohio State University James Cancer Hospital, Columbus, OH.
  • Guzman M; Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Roboz GJ; Division of Hematology and Medical Oncology, Leukemia Program, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.
  • Khoury J; Division of Pathology/Lab Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blood ; 141(6): 567-578, 2023 02 09.
Article em En | MEDLINE | ID: mdl-36399715
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neoplasias Hematológicas / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Aged / Child / Humans País/Região como assunto: America do norte Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neoplasias Hematológicas / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Aged / Child / Humans País/Região como assunto: America do norte Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article